Fulcrum Therapeutics与Slate Medicines以全股交易合并(FULC:NASDAQ)
· seekingalpha.com
Fulcrum Therapeutics与Slate Medicines以全股交易合并,推进下一代偏头痛疗法,并获2.45亿美元融资支持。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...